1782 related articles for article (PubMed ID: 26390807)
1. Microvesicle- and exosome-mediated drug delivery enhances the cytotoxicity of Paclitaxel in autologous prostate cancer cells.
Saari H; Lázaro-Ibáñez E; Viitala T; Vuorimaa-Laukkanen E; Siljander P; Yliperttula M
J Control Release; 2015 Dec; 220(Pt B):727-37. PubMed ID: 26390807
[TBL] [Abstract][Full Text] [Related]
2. Nanoscale flow cytometry to distinguish subpopulations of prostate extracellular vesicles in patient plasma.
Padda RS; Deng FK; Brett SI; Biggs CN; Durfee PN; Brinker CJ; Williams KC; Leong HS
Prostate; 2019 May; 79(6):592-603. PubMed ID: 30680751
[TBL] [Abstract][Full Text] [Related]
3. Active loading into extracellular vesicles significantly improves the cellular uptake and photodynamic effect of porphyrins.
Fuhrmann G; Serio A; Mazo M; Nair R; Stevens MM
J Control Release; 2015 May; 205():35-44. PubMed ID: 25483424
[TBL] [Abstract][Full Text] [Related]
4. FLIM reveals alternative EV-mediated cellular up-take pathways of paclitaxel.
Saari H; Lisitsyna E; Rautaniemi K; Rojalin T; Niemi L; Nivaro O; Laaksonen T; Yliperttula M; Vuorimaa-Laukkanen E
J Control Release; 2018 Aug; 284():133-143. PubMed ID: 29906554
[TBL] [Abstract][Full Text] [Related]
5. Exosomes are secreted at similar densities by M21 and PC3 human cancer cells and show paclitaxel solubility.
Fisher WS; Tchounwou C; Wei S; Roberts L; Ewert KK; Safinya CR
Biochim Biophys Acta Biomembr; 2022 Apr; 1864(4):183841. PubMed ID: 34953781
[TBL] [Abstract][Full Text] [Related]
6. Graphene oxide stabilized by PLA-PEG copolymers for the controlled delivery of paclitaxel.
Angelopoulou A; Voulgari E; Diamanti EK; Gournis D; Avgoustakis K
Eur J Pharm Biopharm; 2015 Jun; 93():18-26. PubMed ID: 25817600
[TBL] [Abstract][Full Text] [Related]
7. Development of innovative paclitaxel-loaded small PLGA nanoparticles: study of their antiproliferative activity and their molecular interactions on prostatic cancer cells.
Le Broc-Ryckewaert D; Carpentier R; Lipka E; Daher S; Vaccher C; Betbeder D; Furman C
Int J Pharm; 2013 Oct; 454(2):712-9. PubMed ID: 23707251
[TBL] [Abstract][Full Text] [Related]
8. Blood/plasma secretome and microvesicles.
Inal JM; Kosgodage U; Azam S; Stratton D; Antwi-Baffour S; Lange S
Biochim Biophys Acta; 2013 Nov; 1834(11):2317-25. PubMed ID: 23590876
[TBL] [Abstract][Full Text] [Related]
9. Exosome delivered anticancer drugs across the blood-brain barrier for brain cancer therapy in Danio rerio.
Yang T; Martin P; Fogarty B; Brown A; Schurman K; Phipps R; Yin VP; Lockman P; Bai S
Pharm Res; 2015 Jun; 32(6):2003-14. PubMed ID: 25609010
[TBL] [Abstract][Full Text] [Related]
10. Paclitaxel incorporated exosomes derived from glioblastoma cells: comparative study of two loading techniques.
Salarpour S; Forootanfar H; Pournamdari M; Ahmadi-Zeidabadi M; Esmaeeli M; Pardakhty A
Daru; 2019 Dec; 27(2):533-539. PubMed ID: 31317441
[TBL] [Abstract][Full Text] [Related]
11. Hydrotropic polymeric mixed micelles based on functional hyperbranched polyglycerol copolymers as hepatoma-targeting drug delivery system.
Zhang X; Zhang X; Yu P; Han Y; Li Y; Li C
J Pharm Sci; 2013 Jan; 102(1):145-53. PubMed ID: 23132353
[TBL] [Abstract][Full Text] [Related]
12. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
Liu Y; Pan J; Feng SS
Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
[TBL] [Abstract][Full Text] [Related]
13. Highly-purified exosomes and shed microvesicles isolated from the human colon cancer cell line LIM1863 by sequential centrifugal ultrafiltration are biochemically and functionally distinct.
Xu R; Greening DW; Rai A; Ji H; Simpson RJ
Methods; 2015 Oct; 87():11-25. PubMed ID: 25890246
[TBL] [Abstract][Full Text] [Related]
14. Direct comparison of two albumin-based paclitaxel-loaded nanoparticle formulations: is the crosslinked version more advantageous?
Li C; Li Y; Gao Y; Wei N; Zhao X; Wang C; Li Y; Xiu X; Cui J
Int J Pharm; 2014 Jul; 468(1-2):15-25. PubMed ID: 24709221
[TBL] [Abstract][Full Text] [Related]
15. Extracellular vesicle isolation and characterization: toward clinical application.
Xu R; Greening DW; Zhu HJ; Takahashi N; Simpson RJ
J Clin Invest; 2016 Apr; 126(4):1152-62. PubMed ID: 27035807
[TBL] [Abstract][Full Text] [Related]
16. Susceptibility of nanoparticle-encapsulated paclitaxel to P-glycoprotein-mediated drug efflux.
Chavanpatil MD; Patil Y; Panyam J
Int J Pharm; 2006 Aug; 320(1-2):150-6. PubMed ID: 16713148
[TBL] [Abstract][Full Text] [Related]
17. Exosomes from M1-Polarized Macrophages Enhance Paclitaxel Antitumor Activity by Activating Macrophages-Mediated Inflammation.
Wang P; Wang H; Huang Q; Peng C; Yao L; Chen H; Qiu Z; Wu Y; Wang L; Chen W
Theranostics; 2019; 9(6):1714-1727. PubMed ID: 31037133
[No Abstract] [Full Text] [Related]
18. Multidrug resistant tumour cells shed more microvesicle-like EVs and less exosomes than their drug-sensitive counterpart cells.
Lopes-Rodrigues V; Di Luca A; Sousa D; Seca H; Meleady P; Henry M; Lima RT; O'Connor R; Vasconcelos MH
Biochim Biophys Acta; 2016 Mar; 1860(3):618-27. PubMed ID: 26708992
[TBL] [Abstract][Full Text] [Related]
19. In vitro &in vivo targeting behaviors of biotinylated Pluronic F127/poly(lactic acid) nanoparticles through biotin-avidin interaction.
Xiong XY; Guo L; Gong YC; Li ZL; Li YP; Liu ZY; Zhou M
Eur J Pharm Sci; 2012 Aug; 46(5):537-44. PubMed ID: 22538053
[TBL] [Abstract][Full Text] [Related]
20. Paclitaxel-loaded expansile nanoparticles enhance chemotherapeutic drug delivery in mesothelioma 3-dimensional multicellular spheroids.
Lei H; Hofferberth SC; Liu R; Colby A; Tevis KM; Catalano P; Grinstaff MW; Colson YL
J Thorac Cardiovasc Surg; 2015 May; 149(5):1417-24; discussion 1424-25.e1. PubMed ID: 25841659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
